Emmaus Life Sciences, Inc. SEC filings EMMA
Emmaus Life Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 2, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Notification of late filing | Apr 1, 2025 | Dec 31, 2024 |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| NT 10-K | Notification of late filing | Apr 1, 2024 | Dec 31, 2023 |
| D | Filing | Jan 31, 2023 | — |
| D | Filing | Jan 20, 2023 | — |
| D | Filing | Jun 30, 2022 | — |
| NT 10-Q | Notification of late filing | May 17, 2021 | Mar 31, 2021 |
| NT 10-K | Notification of late filing | Mar 31, 2021 | Dec 31, 2020 |
| D | Filing | Feb 16, 2021 | — |
| D/A | Filing | Oct 9, 2020 | — |
| D/A | Filing | Oct 7, 2020 | — |
| D | Filing | Oct 7, 2020 | — |
| D | Filing | Aug 7, 2020 | — |
| NT 10-Q | Notification of late filing | May 18, 2020 | Mar 31, 2020 |
| NT 10-K | Filing | May 15, 2020 | Dec 31, 2019 |
| 25-NSE | Delisting notice | Nov 8, 2019 | — |
| 425 | Current report | Jul 9, 2019 | — |
| EFFECT | Filing | Jun 11, 2019 | — |
| CORRESP | Letter to the SEC | Jun 11, 2019 | — |
| UPLOAD | Letter from the SEC | May 30, 2019 | — |
| 425 | Filing | May 23, 2019 | — |
| 425 | Form 8-k | May 13, 2019 | — |
| CORRESP | Letter to the SEC | May 9, 2019 | — |
| UPLOAD | Letter from the SEC | May 2, 2019 | — |
| 425 | 8-k | Apr 17, 2019 | — |
| 425 | 8-k | Apr 4, 2019 | — |
| 425 | 8-k | Mar 5, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2019 | — |
| 425 | Form 8-k | Feb 22, 2019 | — |
| 425 | Form 8-k | Feb 14, 2019 | — |
| 425 | Form 8k | Feb 4, 2019 | — |
| 425 | Filing | Jan 29, 2019 | — |
| 425 | Filing | Jan 10, 2019 | — |
| 425 | Form 8-k | Jan 7, 2019 | — |
| 425 | Filing | Jan 7, 2019 | — |
| EFFECT | Filing | Dec 21, 2018 | — |
| CORRESP | Letter to the SEC | Dec 20, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2018 | — |
| EFFECT | Filing | Jun 29, 2018 | — |
| CORRESP | Letter to the SEC | Jun 28, 2018 | — |
| EFFECT | Filing | Jun 8, 2018 | — |
| EFFECT | Filing | Jun 8, 2018 | — |
| RW | Filing | May 18, 2018 | — |
| NT 10-Q | Filing | Feb 14, 2018 | Dec 31, 2017 |
| CERTNAS | Auto-generated paper document | Jul 13, 2017 | — |
| EFFECT | Filing | Jul 13, 2017 | — |
| 8-A12B | Filing | Jul 13, 2017 | — |
| CORRESP | Letter to the SEC | Jul 12, 2017 | — |
| CORRESP | Letter to the SEC | Jul 12, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2017 | — |
| EFFECT | Filing | Feb 13, 2017 | — |
| EFFECT | Filing | Feb 10, 2017 | — |
| CORRESP | Letter to the SEC | Feb 10, 2017 | — |
| CORRESP | Letter to the SEC | Feb 10, 2017 | — |
| CORRESP | Letter to the SEC | Jan 25, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2017 | — |
| NT 10-Q | Filing | Feb 17, 2016 | Dec 31, 2015 |
| D/A | Filing | Jan 8, 2016 | — |
| NT 10-K | Filing | Dec 29, 2015 | Sep 30, 2015 |
| UPLOAD | Letter from the SEC | Oct 5, 2015 | — |
| PRER14A | Filing | Sep 30, 2015 | — |
| CORRESP | Letter to the SEC | Sep 30, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 28, 2015 | — |
| D/A | Filing | Jul 2, 2015 | — |
| D | Filing | Sep 30, 2014 | — |
| D | Filing | Sep 30, 2014 | — |
| D | Filing | Jan 30, 2014 | — |
| D | Filing | Sep 17, 2013 | — |
| D | Filing | Jun 14, 2013 | — |
| UPLOAD | Letter from the SEC | May 7, 2013 | — |
| CORRESP | Letter to the SEC | May 6, 2013 | — |
| UPLOAD | Letter from the SEC | May 3, 2013 | — |
| D | Filing | Mar 12, 2013 | — |
| NT 10-Q | Form 12b-25 | Feb 14, 2013 | Dec 31, 2012 |
| SC 14F1 | Form sc 14f1 | Feb 6, 2013 | — |
| NT 10-K | Form nt 10-k | Dec 31, 2012 | Sep 30, 2012 |
| D | Filing | Dec 14, 2012 | — |
| RW | Filing | Oct 29, 2012 | — |
| D | Filing | Sep 7, 2012 | — |
| CERTNAS | Auto-generated paper document | May 8, 2012 | — |
| CERTNAS | Auto-generated paper document | Apr 26, 2012 | — |
| 8-A12B | Filing | Apr 26, 2012 | — |
| D | Filing | Nov 2, 2011 | — |
| D | Filing | Oct 26, 2011 | — |
| D/A | Filing | May 9, 2011 | — |
| EFFECT | Filing | Mar 30, 2011 | — |
| CORRESP | Letter to the SEC | Mar 29, 2011 | — |
| D | Filing | Feb 17, 2011 | — |
| CORRESP | Letter to the SEC | Jan 14, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2010 | — |
| CORRESP | Letter to the SEC | Nov 8, 2010 | — |
| D | Filing | Oct 18, 2010 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2010 | — |
| CORRESP | Letter to the SEC | Sep 27, 2010 | — |
| CORRESP | Letter to the SEC | Aug 31, 2010 | — |
| D/A | Filing | Aug 3, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2010 | — |
| CORRESP | Letter to the SEC | Jul 2, 2010 | — |
| D | Filing | Jun 18, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2010 | — |
| CORRESP | Letter to the SEC | Apr 1, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2010 | — |
| D | Filing | Mar 18, 2010 | — |
| D | Filing | Mar 17, 2010 | — |
| D | Filing | Mar 17, 2010 | — |
| CORRESP | Letter to the SEC | Mar 15, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2010 | — |
| NT 10-K | Filing | Dec 30, 2009 | Sep 30, 2009 |
| UPLOAD | Letter from the SEC | Sep 25, 2009 | — |
| CORRESP | Letter to the SEC | Sep 25, 2009 | — |
| CORRESP | Letter to the SEC | Sep 18, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2009 | — |
| D | Filing | Sep 8, 2009 | — |
| DFRN14A | Filing | Sep 4, 2009 | — |
| DFAN14A | Schedule 14a | Sep 4, 2009 | — |
| DFAN14A | Filing | Sep 4, 2009 | — |
| DFRN14A | Schedule 14a | Sep 4, 2009 | — |
| DFAN14A | Proxy statement | Sep 4, 2009 | — |
| DFAN14A | Filing | Sep 3, 2009 | — |
| DFAN14A | Filing | Sep 3, 2009 | — |
| PREC14A | Filing | Sep 3, 2009 | — |
| DFAN14A | Schedule 14a | Sep 3, 2009 | — |
| DFAN14A | Proxy statement | Sep 3, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2009 | — |
| PREC14A | Filing | Sep 2, 2009 | — |
Showing 128 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EMMA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Torrance, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 822370
- Former names
- MYnd Analytics, Inc. (until Jul 12, 2019); CNS RESPONSE, INC. (until Dec 10, 2015); STRATIVATION, INC. (until Mar 1, 2007); SalesTactix, Inc. (until Aug 23, 2005); AGE RESEARCH INC (until Aug 5, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.